Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt repayments
Ratios

BeOne Medicines (BEIGF) Other Gross PP&E Adjustments (2016 - 2025)

BeOne Medicines (BEIGF) has disclosed Other Gross PP&E Adjustments for 11 consecutive years, with $1.7 billion as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 250.89% to $1.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 billion through Dec 2025, up 250.89% year-over-year, with the annual reading at $1.7 billion for FY2025, 250.89% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $1.7 billion at BeOne Medicines, up from $1.7 billion in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $1.7 billion in Q4 2025, with the low at -$29.8 million in Q4 2023.
  • Average Other Gross PP&E Adjustments over 5 years is $455.1 million, with a median of $263.3 million recorded in 2022.
  • The sharpest move saw Other Gross PP&E Adjustments plummeted 116.73% in 2024, then soared 4545.86% in 2025.
  • Over 5 years, Other Gross PP&E Adjustments stood at $205.8 million in 2021, then surged by 46.02% to $300.5 million in 2022, then tumbled by 109.9% to -$29.8 million in 2023, then soared by 1752.62% to $491.8 million in 2024, then surged by 250.89% to $1.7 billion in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $1.7 billion, $1.7 billion, and $1.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.